MAP3K8 and ovarian carcinoma: To our knowledge, this is the first time that the interplay between MAP3K8 and RSK in regulating cyclin D1 expression is shown in ovarian cancer cells and that RSK is the only key player downstream of MAP3K8 involved in this process.